In prostate cancer, modulation of CTLD4 alters CD147 glycosylation, driving its internalization and the disassembly of adherens junctions, thereby reinforcing the functional association between CD147 and MRC2 (133). This evidence concerns the gene BSG and Familial prostate cancer.